Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Regulation & Policy market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

7 Item(s)

Page 1 of 1

  1. Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

    By: Access China Management Consulting Ltd
    , Published: May-2015
    , Product code: ACMC201505008
    Responding to strong desire of overseas and multinational pharmaceutical manufacturers and domestic pharmaceutical manufacturers to carry out research and development of biosimilar products, this is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration officially issued a technical guidance for development and evaluation of biosimilars and defined the pathway of license approval for biosimilars. Chinese pharmaceutical authorities require that when conducting the research and development of biosimilar products in China, the applicant of biosimilar registration application and its sponsor should be in compliance with the Guidance and follow the pathway of license approval of biosimilars.
    $750.00

  2. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

    By: GlobalData
    , Published: Jan-2015
    , Product code: GDHC0075CHR
    GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
    $1,995.00

  3. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

    By: GlobalData
    , Published: Dec-2014
    , Product code: GDHC0073CHR
    GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
    $1,995.00

  4. Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

    By: Current Partnering
    , Published: Dec-2014
    , Product code: CP2054-
    The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.
    $2,995.00

  5. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

    By: GlobalData
    , Published: Dec-2014
    , Product code: GDHC0072CHR
    GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
    $1,995.00

  6. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

    By: GlobalData
    , Published: Nov-2014
    , Product code: GDHC0074CHR
    GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
    $1,995.00

  7. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

    By: GlobalData
    , Published: May-2014
    , Product code: GDHC0060CHR-
    GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure in the country. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. This resource has been produced using data and information from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
    $1,995.00

7 Item(s)

Page 1 of 1